- ►endojournals.org M Promintzer, M Krebs, J Todoric, A Luger, … - Journal of Clinical Endocrinology & Metabolism, 2007 - Endocrine Soc Context: Recent data suggest that circulating retinol-binding protein (RBP)
might be involved in the pathogenesis of insulin resistance. Moreover, protein C
inhibitor (PCI), which specifically binds retinoic acid, was found to be ... Cited by 25 - Related articles - BL Direct - All 3 versions
J Gómez-Ambrosi, A Rodríguez, V Catalán, B … - Clinical Endocrinology-Oxford, 2008 - pt.wkhealth.com Results: No significant effect of either obesity or diabetes on serum RBP4 was
observed. Serum RBP4 concentrations (measured by either ELISA or Western blot)
did not correlate with body mass index (BMI), body fat or any indicator of ... Cited by 18 - Related articles - All 6 versions
G Efstratiadis, K Tziomalos, DP Mikhailidis, VG … - Current Vascular Pharmacology, 2008 - ingentaconnect.com 1 Department of Nephrology, Aristotle University of Thessaloniki, Hippokration
Hospital, Thessaloniki, Greece; 2 Department of Clinical Biochemistry (Vascular
Prevention Clinic), Royal Free Hospital, Royal Free University College ... Cited by 13 - Related articles - BL Direct - All 2 versions
M von Eynatten, PM Humpert - Expert Review of Molecular Diagnostics, 2008 - ingentaconnect.com Retinol-binding protein-4 (RBP4), a 21-kDa protein synthesized in the liver and
adipose tissue, has recently been described as a murine adipokine involved in
the development of insulin resistance. The expression of the gene encoding ... Cited by 11 - Related articles - All 4 versions
C Erikstrup, OH Mortensen, AR Nielsen, CP … - Diabetes Obes Metab, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 4 - Related articles - All 2 versions
KD Lin, YH Chang, CL Wang, YH Yang, PJ … - Translational Research, 2008 - Elsevier Retinol-binding protein 4 (RBP4) has been found to induce insulin resistance and
to be increased in type 2 diabetes. Thiazolidinediones (TZDs) can improve
insulin sensitivity through the activation of peroxisome ... Cited by 5 - Related articles - All 2 versions
- ►ebmonline.org JP Mills, HC Furr, SA Tanumihardjo - Experimental Biology and Medicine, 2008 - SEBM In addition to its well-established role as the major blood carrier of retinol,
serum retinol-binding protein (RBP) has recently been referred to as "RBP4," a
new adipokine, by members of the diabetic research community (1). This ... Cited by 3 - Related articles - All 6 versions
- ►diabetesjournals.org [PDF] V Papavasileiou, V Liakopoulos, GK Sakkas, … - Diabetes Care, 2008 - Am Diabetes Assoc I n their recent study, Ziegelmeier et al. (1) showed that remnant kidney func-
tion and C-reactive protein are inde- pendently associated with elevated serum
levels of retinol-binding protein (sRBP)-4 in hemodialysis patients. ... Cited by 2 - Related articles - All 5 versions
YH Chang, KD Lin, CL Wang, MC Hsieh, PJ … - Diabetes/metabolism research and reviews - ncbi.nlm.nih.gov BACKGROUND: While some studies have reported that retinol-binding protein 4
(RBP4) might induce insulin resistance, other studies have demonstrated that the
presence of albuminuria in diabetic patients and increased uric acid are ... Cited by 2 - Related articles - All 2 versions
J Axelsson, SM O'Byrne, WS Blaner, JJ Carrero … - Am J Nephrol, 2009 - content.karger.com Introduction: Chronic kidney disease (CKD) is associated with insulin resistance
also in the absence of overt diabetes mellitus. The liver-derived transport
protein retinol-binding protein (RBP) has recently been proposed as a novel ... Cited by 1 - Related articles - All 4 versions
